Article: Canadian Bitcoin ETF turns up heat on U.S. fund managers, regulators

Article - Media, Publications

Canadian Bitcoin ETF turns up heat on U.S. fund managers, regulators

Jeff Benjamin, 12 February 2021

Purpose Investments announced Friday morning that it has been cleared by Canadian securities regulators to launch Purpose Bitcoin ETF (BTCC), which is the first Bitcoin ETF in North America to gain regulatory approval, according to Bloomberg.

The new ETF is scheduled to start trading on the Toronto Stock Exchange next week and will be available to U.S. investors through brokerages that have access to the Canadian exchange.

There are a handful of other active filings awaiting regulatory approval in Canada, as well ETF filings before the Securities and Exchange Commission in the U.S. from VanEck and Bitwise Asset Management. Continue reading “Article: Canadian Bitcoin ETF turns up heat on U.S. fund managers, regulators”

Subject: Van Taylor

Subject of Interest

Nicholas Van Campen Taylor, known as Van Taylor (R-TX) is a committee member of the 116th Congress U.S. House Committee on Financial Services. He is an American businessman and politician from Plano, Texas. He is the U.S. Representative for Texas’ 3rd congressional district. Taylor is a veteran of the Iraq War and a member of the Republican Party, he represented District 8 in the Texas Senate for a single term from 2015 to 2019. He also previously served in the Texas House of Representatives for District 66 in western Collin County. From January 2002 to December 2018, Taylor worked for Churchill Capital Company, a real estate investment banking and principal investment firm, as a real estate investment banker. He previously worked for McKinsey & Company and Trammell Crow Company. He graduated from Harvard University (BA, MBA).

Biography

U.S. House Banking Committee on Financial Services

Article: Berkshire Hathaway Bet Big on Dialysis Giant DaVita. Jim Chanos Thinks It’s a Scam

Article - Media

Berkshire Hathaway Bet Big on Dialysis Giant DaVita. Jim Chanos Thinks It’s a  Scam.

Christine Idzelis, Institutional Investor, 4 December 2019

DaVita provides life-extending dialysis treatment to more than 200,000 patients. But is it gaming the system through questionable donations to the American Kidney Fund?

Read full article.

Comment: Chanos is calling DVA a fraud. Stock was $59 it fell to $53.   Then it went to $115.    NICE WORK.  Buffet too big to cheat?